Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Information

v3.7.0.1
Selected Balance Sheet Information
6 Months Ended
Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Balance Sheet Disclosures [Text Block]
4. Selected Balance Sheet Information
 
Prepaid expenses and other current assets (in thousands)
 
 
 
June 30,
2017
 
December 31,
2016
 
Clinical consulting services refund receivable
 
$
612
 
$
-
 
Prepaid conferences, travel and other expenses
 
 
382
 
 
295
 
Grant receivable
 
 
315
 
 
185
 
Prepaid insurance
 
 
185
 
 
358
 
Prepaid clinical research organizations
 
 
46
 
 
1,677
 
 
 
 
 
 
 
 
 
Total
 
$
1,540
 
$
2,515
 
 
Prepaid clinical research organizations expense is classified as a current asset. The Company makes payments to the clinical research organizations based on agreed upon terms that include payments in advance of study services. The Company anticipates that the majority of the prepaid clinical research organization expenses will be applied to research and development expenses during fiscal year 2017.
 
Property and equipment, net (in thousands)
 
 
 
June 30, 
2017
 
December 31, 
2016
 
Computers and office equipment
 
$
653
 
$
641
 
Leasehold improvements
 
 
439
 
 
439
 
Software
 
 
11
 
 
11
 
 
 
 
1,103
 
 
1,091
 
Less accumulated depreciation and amortization
 
 
(303)
 
 
(186)
 
 
 
 
 
 
 
 
 
Total
 
$
800
 
$
905
 
 
Accrued expenses (in thousands)
 
 
 
June 30,
2017
 
December 31,
2016
 
Accrued clinical consulting services
 
$
1,129
 
$
2,211
 
Accrued manufacturing costs
 
 
368
 
 
14
 
Accrued vendor payments
 
 
249
 
 
400
 
Other accrued expenses
 
 
4
 
 
2
 
 
 
 
 
 
 
 
 
Total
 
$
1,750
 
$
2,627
 
 
Accrued employee benefits (in thousands)
 
 
 
June 30,
2017
 
December 31,
2016
 
Accrued bonus expense
 
$
842
 
$
-
 
Accrued vacation expense
 
 
367
 
 
261
 
Other accrued employee benefits
 
 
-
 
 
52
 
 
 
 
 
 
 
 
 
Total
 
$
1,209
 
$
313